The FDA's Category 2 list restricted 19 peptides from compounding. Now, approximately 14 of them may be coming back. HHS has signaled that peptides previously barred from compounding spanning categories like BREAKING NEWS: HHS @seckennedy just announced that the FDA is taking a step toward restoring science based access by removing 12 peptides from Category 2. FDA is moving them to an independent scientific 2023 FDA approvals: unprecedented volume at moderate value Buy Dihexa 10mg Capsules for Research PEPTIDES SOURCE FDA Drug Approval Stages: From Discovery Through Clinical Trials to Market